Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05680727 · ClinicalTrials.gov registry record · Phase 2

Individualized Functional Connectivity Targeting in aiTBS for Depression

A Phase 2 study of Depression and Depressive Disorder, Major, sponsored by Brigham and Women's Hospital.

Active
Registry status
Phase 2
Development phase
40
Enrollment target
1
Study location

NCT05680727 is a Phase 2 study of Depression and Depressive Disorder, Major that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05680727, a Phase 2 study of Depression and Depressive Disorder, Major, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to estimate the importance of neuroimaging in accelerated intermittent theta burst stimulation (aiTBS) for depression. Participants will receive aiTBS treatment, but they will not know if their treatment spot was found with neuroimaging or head measurements.

Conditions Studied

Depression Depressive Disorder, Major Mood Disorders Mental Disorder Psychiatric Disorder

Interventions

  • PROCEDURE transcranial magnetic stimulation

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-07-15
Est. Completion 2027-03-17
Phase Phase 2

Sponsor

Brigham and Women's Hospital

937 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05680727

The ClinicalTrials.gov registry entry for NCT05680727 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which transcranial magnetic stimulation is the first listed.

NCT05680727 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05680727 about?

NCT05680727 is a clinical study titled "Individualized Functional Connectivity Targeting in aiTBS for Depression". The goal of this clinical trial is to estimate the importance of neuroimaging in accelerated intermittent theta burst stimulation (aiTBS) for depression. Participants will receive aiTBS treatment, but they will not know if their treatment spot was found with neuroimaging or head measurements.

What is the current status of trial NCT05680727?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2023-07-15. Estimated completion is 2027-03-17.

What conditions does trial NCT05680727 study?

This clinical trial studies the following conditions: Depression, Depressive Disorder, Major, Mood Disorders, Mental Disorder, Psychiatric Disorder.

What interventions are being tested in trial NCT05680727?

The interventions under investigation include: transcranial magnetic stimulation (PROCEDURE).

Who is sponsoring clinical trial NCT05680727?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05680727 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depression

All registered trials for this condition

Depressive Disorder, Major

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.